IMPLEO MEDICAL, INC.

St. Paul, MN · Medtech · Private

Minimally-invasive endoscopic injection system for delivering bulking agent to the lower esophagus to treat GERD

Grants
$975K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Endoscopic injection device for submucosal esophageal injection of bulking agents in the treatment of gastroesophageal reflux disease$224,980
Federal grantNational Science Foundation · Phase II · SBIR Phase II: Endoscopic injection device for submucosal esophageal injection of bulking agents in the treatment of gastroesophageal reflux disease$750,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1511Rochal Industries, LLC——
1512Myca Health Inc.—$8.8M
1513INTELLISAFE ANALYTICS LLC——
1514IMPLEO MEDICAL, INC.——
1515IGE IMMUNODIAGNOSTICS & THERAPEUTICS, LLC——
1516FREEFLOW MEDICAL DEVICES LLC—$1K
1517Leith Medical, Inc.—$70K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.